NCT00934154 - Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma | Biotech Hunter

Enrollment

122

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2012

Conditions

Multiple Myeloma

Interventions

DRUG

Thalidomide

100 mg/day continuously for 12 months

DRUG

Melphalan+Prednisolone

Melphalan 2 mg, Prednisolone 16 mg

Trial Locations (9)

Baskent University School of Medicine Education and Research Hospital, Hematology Department, Adana

Ankara Numune Education and Research Hospital,Hematology Department, Ankara

Ankara University School of Medicine, Hematology Department, Ankara

Gazi University School of Medicine, Hematology Department, Ankara

Hacettepe University School of Medicine, Hematology Department, Ankara

Uludag University School of Medicine, Hematology Department, Bursa

Osmangazi University School of Medicine , Hematology Department, Eskişehir

Marmara University School of Medicine, Hematology Department, Istanbul

Akdeniz University School of Medicine , Hematology Department, Antalya

All Listed Sponsors

collaborator

Turkish Society of Hematology Myeloma Study Group

UNKNOWN

lead

Cigdem Sahinbas YILMAZ

INDUSTRY